Twist Bioscience Corp Cash Flow-to-Debt Ratio
Twist Bioscience Corp cash flow-to-debt ratio. Twist Bioscience Corp (TWST) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of $1.11 Million could theoretically repay 0% of its total liabilities ($226.70 Million) in one year. Check Twist Bioscience Corp cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Twist Bioscience Corp (2016–2025)
Cash flow-to-debt ratio of Twist Bioscience Corp from 2016 to 2025. Historical debt coverage capacity for Twist Bioscience Corp across 10 annual periods. Check TWST total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Twist Bioscience Corp Cash Flow-to-Debt Ratio by Year (2016–2025)
Twist Bioscience Corp cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Twist Bioscience Corp. For the full cash flow conversion analysis, see cash efficiency ratio of Twist Bioscience Corp.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.28x | $-47.63 Million | $168.90 Million | ▲ +37.7% |
| 2024 | -0.45x | $-64.09 Million | $141.63 Million | ▲ +51.4% |
| 2023 | -0.93x | $-142.47 Million | $152.97 Million | ▼ -28.8% |
| 2022 | -0.72x | $-124.39 Million | $171.99 Million | ▲ +21.9% |
| 2021 | -0.93x | $-112.24 Million | $121.28 Million | ▲ +59.3% |
| 2020 | -2.27x | $-142.25 Million | $62.62 Million | ▲ +9.8% |
| 2019 | -2.52x | $-87.94 Million | $34.91 Million | ▼ -1107.6% |
| 2018 | -0.21x | $-66.16 Million | $317.21 Million | ▲ +11.0% |
| 2017 | -0.23x | $-51.30 Million | $219.01 Million | ▲ +7.1% |
| 2016 | -0.25x | $-38.59 Million | $153.07 Million | — |